AFP and neoplasm: Recent in vitro studies have demonstrated that tumour-derived AFP can directly impair natural killer (NK) cell activation and viability [32], indirectly impair NK cell activity through suppression of dendritic cell function [33], and induce aberrant dendritic cell differentiation with consequential reduction in the secretion of inflammatory cytokines and chemokines and limited T cell activation [34, 35].